loading
前日終値:
$58.01
開ける:
$58.28
24時間の取引高:
689.82K
Relative Volume:
2.00
時価総額:
$1.21B
収益:
$1.77M
当期純損益:
$-123.74M
株価収益率:
-6.458
EPS:
-9.17
ネットキャッシュフロー:
$-95.21M
1週間 パフォーマンス:
+9.97%
1か月 パフォーマンス:
+36.67%
6か月 パフォーマンス:
-23.20%
1年 パフォーマンス:
+2.92%
1日の値動き範囲:
Value
$56.66
$61.03
1週間の範囲:
Value
$53.88
$61.03
52週間の値動き範囲:
Value
$26.70
$91.83

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name
名前
Praxis Precision Medicines Inc
Name
セクター
Healthcare (1164)
Name
電話
617-300-8460
Name
住所
99 HIGH STREET, 30TH FLOOR, BOSTON
Name
職員
82
Name
Twitter
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
PRAX's Discussions on Twitter

PRAX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PRAX
Praxis Precision Medicines Inc
59.22 1.18B 1.77M -123.74M -95.21M -9.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-02 再開されました Oppenheimer Outperform
2025-05-07 開始されました Chardan Capital Markets Buy
2025-03-03 繰り返されました H.C. Wainwright Buy
2025-02-11 開始されました Deutsche Bank Buy
2024-08-05 開始されました Oppenheimer Outperform
2024-06-24 開始されました Needham Buy
2024-06-18 開始されました Guggenheim Buy
2024-05-01 開始されました Robert W. Baird Outperform
2023-09-19 開始されました Truist Buy
2022-06-06 ダウングレード Wedbush Outperform → Neutral
2021-12-16 開始されました H.C. Wainwright Buy
2021-08-26 開始されました BofA Securities Buy
2021-04-26 開始されました William Blair Outperform
2020-11-11 開始されました Wedbush Outperform
2020-11-10 開始されました Cowen Outperform
2020-11-10 開始されました Evercore ISI Outperform
2020-11-10 開始されました Piper Sandler Overweight
すべてを表示

Praxis Precision Medicines Inc (PRAX) 最新ニュース

pulisher
Jul 25, 2025

What analysts say about Praxis Precision Medicines Inc. stock outlookFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Why Praxis Precision Medicines Inc. stock attracts strong analyst attentionGroup Only Stock Signals - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

Will Praxis Precision Medicines Inc. stock benefit from AI tech trendsPhenomenal capital gains - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What makes Praxis Precision Medicines Inc. stock price move sharplyShort Squeeze Radar - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

Praxis Precision Medicines Inc. Stock Analysis and ForecastTremendous return on equity - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

Is Praxis Precision Medicines Inc. a good long term investmentExceptional profit potential - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Praxis Precision Medicines Inc. stock priceConsistent triple-digit returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Praxis Precision Medicines Inc. stockBreakthrough capital growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Major Depressive Disorder Clinical Trials, Companies, - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

Does Praxis Precision Medicines Inc. stock pay reliable dividendsShort Squeeze Radar - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Praxis Precision Medicines’ (PRAX) Buy Rating Reiterated at HC Wainwright - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

(PRAX) Trading Report - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

Here's Why We're Not Too Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Situation - 富途牛牛

Jul 19, 2025
pulisher
Jul 18, 2025

Praxis Precision Medicines stock gets BTD for relutrigine, H.C. Wainwright maintains Buy - Investing.com Nigeria

Jul 18, 2025
pulisher
Jul 18, 2025

Praxis Precision Medicines stock gets BTD for relutrigine, H.C. Wainwright maintains Buy By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

PRAX: HC Wainwright & Co. Reiterates Buy Rating with $105 Target - GuruFocus

Jul 18, 2025
pulisher
Jul 17, 2025

Praxis Precision gets FDA breakthrough therapy status for Relutrigine - Seeking Alpha

Jul 17, 2025
pulisher
Jul 17, 2025

FDA grants breakthrough therapy designation to Praxis’ relutrigine for pediatric epilepsy - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Q1 Earnings Forecast for PRAX Issued By HC Wainwright - Defense World

Jul 17, 2025
pulisher
Jul 17, 2025

Praxis Precision Medicines and the Breakthrough Potential of Relutrigine in Rare Epilepsy Therapies: Strategic and Financial Implications of FDA Breakthrough Therapy Designation - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Praxis Says FDA Grants Breakthrough Therapy Designation To Relutrigine For Rare Pediatric Epilepsies - Nasdaq

Jul 17, 2025
pulisher
Jul 17, 2025

FDA grants breakthrough therapy status to Praxis’s relutrigine By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

FDA grants breakthrough therapy status to Praxis’s relutrigine - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Praxis Precision Medicines Gains FDA Breakthrough Designation - TipRanks

Jul 17, 2025

Praxis Precision Medicines Inc (PRAX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Praxis Precision Medicines Inc (PRAX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Nemiroff Alex
General Counsel and Secretary
Nov 14 '24
Sale
80.20
8,239
660,827
10,301
Mastrocola Lauren
Principal Accounting Officer
Nov 14 '24
Option Exercise
56.94
4,374
249,056
10,801
Mastrocola Lauren
Principal Accounting Officer
Nov 14 '24
Sale
81.78
5,188
424,318
5,613
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):